Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 1
1985 1
1986 1
1989 2
1990 1
1993 1
1996 1
1997 1
1999 1
2000 1
2001 1
2002 3
2003 3
2004 1
2005 3
2007 2
2008 2
2009 1
2010 2
2011 2
2012 2
2013 1
2014 3
2015 4
2016 2
2017 1
2019 3
2020 3
2021 8
2022 3
2023 2
2024 5
2025 6
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for narrow, insomnia
Search for yarrow, insomnia instead (1 results)
Pharmacological Management of Insomnia.
Madari S, Golebiowski R, Mansukhani MP, Kolla BP. Madari S, et al. Neurotherapeutics. 2021 Jan;18(1):44-52. doi: 10.1007/s13311-021-01010-z. Epub 2021 Feb 1. Neurotherapeutics. 2021. PMID: 33527255 Free PMC article. Review.
Insomnia is a highly prevalent condition associated with significant morbidity, reduction in quality of life, and increase in healthcare costs, and is a risk factor for multiple physical and mental disorders. ...Older medications for insomnia are limited by t …
Insomnia is a highly prevalent condition associated with significant morbidity, reduction in quality of life, and increase in healthc …
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis.
Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Trauer JM, et al. Ann Intern Med. 2015 Aug 4;163(3):191-204. doi: 10.7326/M14-2841. Ann Intern Med. 2015. PMID: 26054060
STUDY SELECTION: Randomized, controlled trials assessing the efficacy of face-to-face, multimodal CBT-i compared with inactive comparators on overnight sleep in adults with chronic insomnia. Studies of insomnia comorbid with medical, sleep, or psychiat …
STUDY SELECTION: Randomized, controlled trials assessing the efficacy of face-to-face, multimodal CBT-i compared with inactive comparators o …
Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC. Shelton RC. Handb Exp Pharmacol. 2019;250:145-180. doi: 10.1007/164_2018_164. Handb Exp Pharmacol. 2019. PMID: 30838456
However, the primary metabolic pathway is direct conjugation. It is approved in the narrow dose range of 50-100 mg per day. Duloxetine is a more potent 5-HT and NE reuptake inhibitor with a more balanced profile of binding at about 10:1 for 5HT and NE transporter binding. …
However, the primary metabolic pathway is direct conjugation. It is approved in the narrow dose range of 50-100 mg per day. Duloxetin …
Barbiturate Toxicity.
Suddock JT, Kent KJ, Regina AC, Cain MD. Suddock JT, et al. 2024 Feb 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2024 Feb 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 29763050 Free Books & Documents.
Over the past 120 years, barbiturates have been used for a broad spectrum of indications, including insomnia, psychiatric disorders, anesthesia, alcohol withdrawal, seizures, and elevated intracranial pressure. These drugs have a narrow therapeutic index, are …
Over the past 120 years, barbiturates have been used for a broad spectrum of indications, including insomnia, psychiatric disorder …
Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation.
Li XY, Li K, Wei YH, Yu WK, Wu JH, Gao K, He WJ, Niu PP, Zhang C, Cheng YN, Li YS. Li XY, et al. Sci Rep. 2025 Jul 20;15(1):26365. doi: 10.1038/s41598-025-12553-y. Sci Rep. 2025. PMID: 40685483 Free PMC article.
Cerebral amyloid angiopathy (CAA) and insomnia are age-related neurological disorders increasingly recognized as being closely associated. ...This study aims to identify common genes between CAA and insomnia and explore their potential molecular mechanisms, o …
Cerebral amyloid angiopathy (CAA) and insomnia are age-related neurological disorders increasingly recognized as being closely …
Clinical insomnia among elderly primary care attenders in Wuhan, China: A multicenter cross-sectional epidemiological study.
Zhong BL, Li HJ, Xu YM, Jiang XF. Zhong BL, et al. Front Public Health. 2022 Oct 21;10:1026034. doi: 10.3389/fpubh.2022.1026034. eCollection 2022. Front Public Health. 2022. PMID: 36339226 Free PMC article.
BACKGROUND AND OBJECTIVES: Integrating sleep health into primary care is a promising approach to narrow the treatment gap for insomnia in older adults but data regarding the epidemiological characteristics of insomnia among elderly primary care attende …
BACKGROUND AND OBJECTIVES: Integrating sleep health into primary care is a promising approach to narrow the treatment gap for …
Orexin research: patent news from 2016.
Boss C, Roch C. Boss C, et al. Expert Opin Ther Pat. 2017 Oct;27(10):1123-1133. doi: 10.1080/13543776.2017.1344221. Epub 2017 Jun 28. Expert Opin Ther Pat. 2017. PMID: 28631980 Review.
It is involved in the promotion of wakefulness as well as in anxiety and addictive disorders. In addition, its activation via the Ox1 receptor triggers apoptosis in several cancer cell lines. Dual orexin receptor antagonists are successfully used to treat primary insomn …
It is involved in the promotion of wakefulness as well as in anxiety and addictive disorders. In addition, its activation via the Ox1 …
Measuring outcomes in randomized clinical trials of insomnia treatments.
Morin CM. Morin CM. Sleep Med Rev. 2003 Jun;7(3):263-79. doi: 10.1053/smrv.2002.0274. Sleep Med Rev. 2003. PMID: 12927124 Review.
Significant efforts have been made in the last decade to develop evidence-based guidelines for the treatment of insomnia and other sleep disorders. Despite such progress, there are still no standard assessment methods to document outcome and no accepted crite …
Significant efforts have been made in the last decade to develop evidence-based guidelines for the treatment of insomnia and other …
The natural history of insomnia: acute insomnia and first-onset depression.
Ellis JG, Perlis ML, Bastien CH, Gardani M, Espie CA. Ellis JG, et al. Sleep. 2014 Jan 1;37(1):97-106. doi: 10.5665/sleep.3316. Sleep. 2014. PMID: 24470699 Free PMC article.
STUDY OBJECTIVES: While many studies have examined the association between insomnia and depression, no studies have evaluated these associations (1) within a narrow time frame, (2) with specific reference to acute and chronic insomnia, and (3) using polysomno …
STUDY OBJECTIVES: While many studies have examined the association between insomnia and depression, no studies have evaluated these a …
[Sleep disorders and mental health].
Habermeyer B, Huber M, Spielmanns M. Habermeyer B, et al. Ther Umsch. 2026 Feb;83(1):27-32. doi: 10.23785/TU.2026.01.005. Ther Umsch. 2026. PMID: 41878755 Review. German.
Even in the most common sleep disorders, namely sleep-related breathing disorders, insomnia, and restless legs syndrome / periodic limb movement disorder, reciprocal and sometimes complex interactions between sleep and the mental health a …
Even in the most common sleep disorders, namely sleep-related breathing disorders, insomnia, and restless …
78 results